Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
Marsha E ReichmanMichael WerneckeDavid J GrahamJiemin LiaoJohn YapYoganand ChillarigeMary Ross SouthworthStephine KeetonMargie R GouldingKatrina MottJeffrey A KelmanPublished in: Pharmacoepidemiology and drug safety (2017)
There was significant effect modification of angioedema risk by race and ACEI use for blacks, but not for other race/ethnicity groups. Angioedema risk was significantly greater in the first 30 days of exposure for all, and highest among blacks.